SUMMARY We describe a method of screening for dihydropteridine reductase deficiency and dihydrobiopterin synthesis deficiency-the two inherited defects that cause tetrahydrobiopterin deficiency-using blood spots on Guthrie cards. Dihydropteridine reductase deficiency may be identified positively, and a biopterin value of <6-0 [ig/l in the presence of hyperphenylalaninaemia indicates further investigation for dihydrobiopterin synthesis deficiency.
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Tetrahydropbiopterin deficiency can arise from defective synthesis of dihydrobiopterin,' 2 or from lack of dihydropteridine reductase activity, 23 and is a cause of neonatal hyperphenylalaninaemia. Routine screening for phenylketonuria depends upon detection of raised phenylalanine values but does not distinguish hyperphenylalaninaemia arising from tetrahydrobiopterin deficiency from the far more common cause of hyperphenylalaninaemia, phenylalanine hydroxylase deficiency. Tetrahydrobiopterin is the cofactor for the hydroxylation of tyrosine4 and tryptophan5 as well as phenylalanine.
Patients with cofactor deficiency develop gross lack of serotonin, dopamine, and noradrenaline. Phenylalanine restriction alone is not the appropriate treatment for these patients who require additional treatment with L-dopa, carbidopa and 5-hyd- We describe the routine use of a Guthrie card technique for measurement of dihydropteridine reductase activity and total biopterins in a series of 44 infants with hyperphenylalaninaemia detected on routine neonatal screening.
Methods
Guthrie cards bearing four blood spots were sent through the post from phenylketonuria clinics and screening centres in Britain, France, and Eire. Many of the neonates with positive screening tests for phenylketonuria, had already begun treatment by the time blood was taken for biopterin assay. For comparison with the neonates, 14 older children with phenylketonuria, 19 normal adults, and 9 patients with known tetrahydrobiopterin deficiency were also tested.
When the cards arrived in the laboratory two 8 mm discs were cut into 4-0 ml phosphate buffer pH 5-0, the solution and discs were frozen at -20°C, and later autoclaved for three minutes at 115°C to deproteinise and to elute the biopterin for bioassay with the protozoon Crithidiafasciculata. 13 This assay provides a measure of the combined activity of tetrahydrobiopterin, dihydrobiopterin, biopterin, and sepiapterin. The remaining blood spots were stored at -20°C in sealed plastic bags and were later eluted for dihydropteridine reductase assay. Each incubation contained 0-05 M Tris buffer pH 75, 10-4 M NADH, 5 x 10-5M cytochrome C (Sigma, type III), and 10-5M 6-methyl 5, 6, 7, 8-tetrahydropterin with appropriate enzyme solution in a total volume of 1 ml. Plasma phenylalanine results were provided by the centres that generated the samples.
Results
Dihydropteridine reductase assays on blood spots from the neonates with hyperphenylalaninaemia gave results similar to those found in normal adults and older patients with phenylketonuria not caused by dihydropteridine reductase deficiency (Table) . The neonatal Guthrie card biopterin values correlated closely with phenylalanine concentrations (see Figure) . In those infants on a restricted phenylalanine intake, with plasma phenylalanine concentrations within or close to the normal range, biopterin values were similar to those in normal adults and in patients with defective dihydrobiopterin synthesis (see below and Table) . The lower limit of the Guthrie card bioassay was 2*4 ,ug/l and 7 normal subjects, three synthesis deficient patients, and 1 neonate with treated phenylketonuria had values below this. Older children with phenylketonuria also showed biopterin values that correlated closely with those of phenylalanine.
No neonates with suspected tetrahydrobiopterin deficiency were examined during the course of the study. Examination of Guthrie cards from three patients of various ages known to have dihydropteridine reductase deficiency showed that they had even more notably raised blood biopterin concentrations than patients with phenylalanine hydroxylase deficiency, and very low dihydropteridine reductase activity. The enzyme assay distinguished obligate heterozygotes (parents) from normal.
Six patients with disorders of biopterin synthesis (complete in two and partial in four) had Guthrie card biopterin results indistinguishable from those of normal adults and those found in the neonates whose phenylalanine concentrations were normal or near normal. These results contrasted with plasma measurements on the same patients that gave low biopterin values. None of the neonates with phenylketonuria who had phenylalanine values above 600 gimol/l had Guthrie card biopterin values below [ig/l (see Figure) , whereas the highest biopterin value on a patient with dihydrobiopterin synthesis deficiency was 4*8 ,ug/l. Clearly, separation between patients with dihydrobiopterin synthesis deficiency and phenylalanine hydroxylase deficiency is best when phenylalanine values are high.
Discussion
The results of the present study suggest that dried blood spots from Guthrie cards can be used to screen for the two types of tetrahydrobiopterin deficiency occurring among infants with neonatal hyperphenylalaninaemia, provided that the limitations of the method are recognised. Patients with dihydropteridine reductase deficiency have results that enable them to be easily identified. On the other hand to achieve reasonable separation between patients with defects of dihydrobiopterin synthesis and those with phenylalanine hydroxylase deficiency it is most important to ensure that the Guthrie card specimens are obtained while the patient is on a normal protein intake when phenylalanine values are maximal. When phenylalanine values are below 600 ZImol/l, either because a low phenylalanine diet has been introduced or because a partial block is present, biopterin values in patients with hydroxylase deficiency overlap with those in patients with a defect of dihydrobiopterin synthesis.
We suggest that any neonate with a Guthrie card biopterin value below 6 ,ug/l should be investigated further for the possible presence of tetrahydrobiopterin deficiency. This is probably best done by a combination of an oral load of tetrahydrobiopterin14 (7.5 
